|
Current Events |
Verma Family gifts $25,000 to establish Vijay and Shiksha Verma Family Endowment Fund for TRIUMF |
07 January 2022 |
TRIUMF is pleased to announce that Vijay Verma, Researcher Emeritus and alumnus, and his wife Shiksha have made a generous contribution of $25,000 to establish the Vijay and Shiksha Verma Family Endowment Fund |
|
|
Current Events |
TRIUMF’s DRAGON celebrates 20th anniversary |
05 November 2021 |
The DRAGON experiment has been a mainstay in TRIUMF’s scientific portfolio since 2001, measuring the majority of the world’s radiative capture reactions with rare isotope beams so far and, in the process, making a number of first-in-the-world measurements. |
|
|
Current Events |
Work Integrated Learning brings 360° experiential learning for TRIUMF |
27 October 2021 |
After more than a year of virtual sessions, TRIUMF’s Work Integrated Learning program is bringing together the laboratory’s co-op employees, graduate students, and post-docs for a suite of hands-on 360° experiential learning. Led by Vishnu Vardhan, TRIUMF’s Lead for Work Integrated Learning, the in-person activities explore a variety of professional skills aimed at augmenting the technical training students receive in their roles at the laboratory. |
|
|
Current Events |
E-linac teams hit 2021 commissioning target ahead of schedule |
13 October 2021 |
Teams working on TRIUMF’s Advanced Rare Isotope Laboratory (ARIEL) achieved a major milestone for the facility’s electron linear accelerator (e-linac) by reaching an average beam power of 10 kW at the e-linac's design energy of 30 MeV. The results, which come nearly three months ahead of schedule, mark a major leap in the ramp-up of the accelerator’s output to full capacity and eventual operation. |
|
|
Current Events |
TRIUMF and Fusion Pharmaceuticals announce expanded R&D collaboration for Actinium Supply Production |
12 August 2021 |
The clinical-stage oncology company and TRIUMF announced their entry into the next phase of their collaboration agreement for the production of actinium-225. |
|
|
Current Events |
Dr. Jens Dilling to become Director of Institutional Strategic Planning at ORNL |
02 July 2021 |
After 20 years of service to TRIUMF, Jens Dilling will be departing the laboratory on July 31, 2021 to take on a new challenge as the Director of Institutional Strategic Planning at Oak Ridge National Laboratory in Tennessee. |
|
|
Current Events |
TRIUMF joins RADNEXT infrastructure network |
21 June 2021 |
TRIUMF has joined RADNEXT (‘RADiation facility Network for the EXploration of effects for indusTry and research’), a Horizons 2020 infrastructure project that will establish a global network of facilities and related irradiation methodology for responding to the emerging needs of electronics component and system irradiation. |
|
|
From the Director |
An Update on TRIUMF Incorporation |
12 March 2021 |
TRIUMF is entering the final stages of its effort to move from a joint venture to an incorporated non-profit with charitable status. On March 5, 2021, the TRIUMF Board of Management confirmed its intention that this process should be completed by June 1, 2021. |
|
|
Funding Announcements |
CFI announces major investments in TRIUMF-related projects |
03 March 2021 |
The Canada Foundation for Innovation (CFI) today announced over $23M in support for five TRIUMF-related research projects. |
|
|
Funding Announcements |
Ignite program fuels TRIUMF partnership with $300k award for advancement of zirconium-89 production |
25 February 2021 |
Innovate BC has announced $300,000 in funding through the Ignite program for TRIUMF and ARTMS to further develop and validate the production of zirconium-89 (Zr-89) for use in PET imaging scans for cancer patients eligible for immuno-oncology (IO) therapies. |
|
